Earnings Feed
Start Free
Home/Filings/4/0001181431-14-029728
4//SEC Filing

ACHILLION PHARMACEUTICALS INC 4

Accession 0001181431-14-029728

CIK 0001070336operating
View on SEC.govCompany Profile

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 6:11 PM ET

Size

23.2 KB

Accession

0001181431-14-029728

Insider Transaction Report

Form 4
Period: 2014-08-18
ACHILLION PHARMACEUTICALS INCACHN
Deshpande Milind
EVP and CSO
Transactions
  • Sale

    Common Stock

    2014-08-18$10.00/sh−16,250$162,500→ 0 total
  • Exercise/Conversion

    Common Stock

    2014-08-18$1.05/sh+15,950$16,748→ 15,950 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2014-08-18−15,950→ 0 total
    Exercise: $1.05Exp: 2018-12-15→ Common Stock (15,950 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2014-08-18−124,424→ 75,576 total
    Exercise: $3.10Exp: 2020-12-16→ Common Stock (124,424 underlying)
  • Exercise/Conversion

    Common Stock

    2014-08-18$4.00/sh+16,250$65,000→ 16,250 total
  • Sale

    Common Stock

    2014-08-18$10.00/sh−15,950$159,500→ 0 total
  • Exercise/Conversion

    Common Stock

    2014-08-18$3.28/sh+60,000$196,800→ 60,000 total
  • Exercise/Conversion

    Common Stock

    2014-08-18$3.10/sh+124,424$385,714→ 124,424 total
  • Sale

    Common Stock

    2014-08-18$10.00/sh−124,424$1,244,240→ 0 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2014-08-18−16,250→ 0 total
    Exercise: $4.00Exp: 2015-12-20→ Common Stock (16,250 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2014-08-18−60,000→ 0 total
    Exercise: $3.28Exp: 2019-12-18→ Common Stock (60,000 underlying)
  • Sale

    Common Stock

    2014-08-18$10.00/sh−60,000$600,000→ 0 total
Footnotes (4)
  • [F1]This option was granted on December 20, 2005 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  • [F2]This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  • [F3]This option was granted on December 18, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  • [F4]This option was granted on December 16, 2010 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.

Documents

1 file

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070336

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:11 PM ET
Size
23.2 KB
View on SEC.gov